Diabetes News and Research

Latest Diabetes News and Research

Protein adenylyl cyclase senses and regulates pH blood levels

Researchers have identified the protein mechanism that senses bicarbonate fluctuations and adjusts blood pH levels.. A Canadian/U.S. research team led by University of Alberta biological sciences professor, Greg Goss and his graduate students Martin Tresguerres and Scott Parks achieved the first demonstration of the process in a whole animal. The researchers found that the protein adenylyl cyclase sensed and then regulated the pH blood levels in a dogfish shark following feeding.

23 Dec 2009

CVS/pharmacy to provide H1N1 flu vaccinations at select store locations in Rhode Island

CVS/pharmacy announced today that it will provide H1N1 flu vaccinations at select store locations in Rhode Island by the end of this week. The vaccine will be available to all Rhode Islanders who wish to be vaccinated while supplies last.

23 Dec 2009

Researchers develop new approach for treating and healing skin abscesses

Researchers at the Albert Einstein College of Medicine of Yeshiva University have developed a new approach for treating and healing skin abscesses caused by bacteria resistant to most antibiotics.

23 Dec 2009

Hispanics should consider healthy sight as a key resolution for New Year

As a new decade begins, more Hispanics share in the desire to better themselves by making a New Year's resolution list. Many will start off the year trying to live healthier lifestyles through exercise, a proper diet and regular visits to healthcare professionals. One aspect of overall health and wellness that often gets overlooked is eye health. It's important for Hispanics to include a comprehensive eye exam on their New Year's resolution list to improve their quality of vision throughout the year.

23 Dec 2009

Kaiser Permanente approves $2.1 million in grants and donations to promote healthy eating

With hunger in America reaching its highest level in 14 years, Kaiser Permanente has quadrupled the amount it invests in programs to promote healthy eating during difficult economic times.

23 Dec 2009

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).

23 Dec 2009

Riverside Medical Center launches new diabetes prevention program

Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.

23 Dec 2009

Australian scientists show connections between brain and regulation of bone mass

The brain acts as a profound regulatory centre, controlling myriad processes throughout the body in ways we are only just beginning to understand. In new findings, Australian scientists have shown surprising connections between the brain and regulation of bone mass.

23 Dec 2009

High prevalence of type 2 diabetes may be linked to excess niacin intake

Facing the increasing prevalence of type 2 diabetes worldwide in the past few decades, one may ask what is wrong with humans. Geneticists tell us that the human genome has not changed markedly in such a short time.

23 Dec 2009

Niacin may not be beneficial for type 2 diabetic patients

High-density lipoprotein (HDL), known as "good" cholesterol, isn't as protective for people with type 2 diabetes, according to research reported in Circulation: Journal of the American Heart Association.

22 Dec 2009

Monitoring blood glucose levels with contact lenses may soon be a reality for diabetes patients

Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours - replacing the need to routinely draw blood throughout the day.

22 Dec 2009

LA BioMed physician-researchers named Super Doctors in the Los Angeles Magazine

Los Angeles Magazine, in its January issue, will name 37 of the physician-researchers at Los Angeles Biomedical Research Institute (LA BioMed) to be among Southern California Super Doctors.

22 Dec 2009

Endocannabinoid modulation of sweet taste receptors may help control feeding behavior

Sweet taste responses were enhanced by endocannabinoids in every case. The effect was specific for sweet taste, as endocannibinoids had no effect on responses to sour, salty, bitter or umami taste stimuli.

22 Dec 2009

Darbepoetin alfa does not reduce cardiovascular problem in anemic patients on dialysis

An international study authored by a UT Southwestern Medical Center researcher has concluded that the anemia drug darbepoetin alfa works no better than a placebo in several other applications previously thought to be promising.

22 Dec 2009

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.

22 Dec 2009

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

Arena Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss. The submission is based on an extensive data package from lorcaserin's clinical development program that includes 18 clinical trials totaling 8,576 patients.

22 Dec 2009

OSI Pharmaceuticals provides update to ODAC meeting

OSI Pharmaceuticals, Inc. today provided an update to the preliminary revenue and adjusted earnings per share growth rate guidance provided to investors at the Company’s recent analyst R&D day meeting on December 3, 2009. The Company now believes that the 2010 overall revenue percentage growth rate will be in the mid-teens and re-affirms that adjusted earnings per share will grow at 10% or more.

22 Dec 2009

iGuard registers 2 million subscribers in just over 2 years

iGuard, a drug safety system that monitors patient medications for drug interactions, safety alerts and recalls, today announced it has registered 2 million subscribers in just over 2 years - matching the early growth rate of the popular social networking tool Twitter.

22 Dec 2009

Health and education leaders commend school for promoting physical activity among students

During a visit today to Conrad Weiser Middle School, Department of Health Secretary Everette James and Secretary of Education Gerald Zahorchak commended the school for its efforts to increase physical activity among students.

22 Dec 2009

Veolia Energy North America signs long-term agreement to operate MATEP assets in Boston

Veolia Energy North America, a leading provider of sustainable energy services, management solutions, and facility operations is pleased to announce that it has entered into a long-term agreement to operate and maintain the Medical Area Total Energy Plant (MATEP) assets in the Longwood Medical Area of Boston.

22 Dec 2009

Diabetes News and Research

Latest Diabetes News and Research

Protein adenylyl cyclase senses and regulates pH blood levels

CVS/pharmacy to provide H1N1 flu vaccinations at select store locations in Rhode Island

Researchers develop new approach for treating and healing skin abscesses

Hispanics should consider healthy sight as a key resolution for New Year

Kaiser Permanente approves $2.1 million in grants and donations to promote healthy eating

US Phase 2 clinical trial of RVX-208 commenced by Resverlogix

Riverside Medical Center launches new diabetes prevention program

Australian scientists show connections between brain and regulation of bone mass

High prevalence of type 2 diabetes may be linked to excess niacin intake

Niacin may not be beneficial for type 2 diabetic patients

Monitoring blood glucose levels with contact lenses may soon be a reality for diabetes patients

LA BioMed physician-researchers named Super Doctors in the Los Angeles Magazine

Endocannabinoid modulation of sweet taste receptors may help control feeding behavior

Darbepoetin alfa does not reduce cardiovascular problem in anemic patients on dialysis

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

OSI Pharmaceuticals provides update to ODAC meeting

iGuard registers 2 million subscribers in just over 2 years

Health and education leaders commend school for promoting physical activity among students

Veolia Energy North America signs long-term agreement to operate MATEP assets in Boston

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Diabetes News and Research

Latest Diabetes News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in